The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3,5-dimethyl-4-(4-(pyridin-4-yl)-1H-pyrazol-5-yl)isoxazole ID: ALA4749457
Chembl Id: CHEMBL4749457
PubChem CID: 95857692
Max Phase: Preclinical
Molecular Formula: C13H12N4O
Molecular Weight: 240.27
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1noc(C)c1-c1[nH]ncc1-c1ccncc1
Standard InChI: InChI=1S/C13H12N4O/c1-8-12(9(2)18-17-8)13-11(7-15-16-13)10-3-5-14-6-4-10/h3-7H,1-2H3,(H,15,16)
Standard InChI Key: JYTPHNOPQGAILG-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 240.27Molecular Weight (Monoisotopic): 240.1011AlogP: 2.74#Rotatable Bonds: 2Polar Surface Area: 67.60Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.80CX Basic pKa: 4.27CX LogP: 0.97CX LogD: 0.97Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.75Np Likeness Score: -1.56
References 1. Jahnke W,Erlanson DA,de Esch IJP,Johnson CN,Mortenson PN,Ochi Y,Urushima T. (2020) Fragment-to-Lead Medicinal Chemistry Publications in 2019., 63 (24): [PMID:33226222 ] [10.1021/acs.jmedchem.0c01608 ] 2. Vaidergorn MM, da Silva Emery F, Ganesan A.. (2021) From Hit Seeking to Magic Bullets: The Successful Union of Epigenetic and Fragment Based Drug Discovery (EPIDD + FBDD)., 64 (19.0): [PMID:34591474 ] [10.1021/acs.jmedchem.1c00787 ]